博润

最新新闻

• 公司公告
  Cabaletta Bio | 4: Statement of changes in beneficial ownership of securities-Director Brun Scott C.
  SEC · 2025/6/10
• Northland Securities Maintains Boost Run(BRUN.US) With Buy Rating, Maintains Target Price $36
  \u5e02\u573a\u8d44\u8baf · 2026/9/28
• 评级变动
  Craig-Hallum Maintains Boost Run(BRUN.US) With Buy Rating, Announces Target Price $45
  \u5e02\u573a\u8d44\u8baf · 2026/6/23
• 评级变动
  Craig-Hallum Maintains Boost Run(BRUN.US) With Buy Rating, Maintains Target Price $45
  \u5e02\u573a\u8d44\u8baf · 2026/7/2
• 评级变动
  Craig-Hallum Initiates Boost Run(BRUN.US) With Buy Rating, Announces Target Price $30
  \u5e02\u573a\u8d44\u8baf · 2026/5/12
• 评级变动
  Analysts Offer Insights on NA Companies: Amrize Ltd (AMRZ), Curbline Properties Corp. (CURB) and Boost Run (BRUN)
  TipRanks · 2026/8/17
• Analysts Offer Insights on NA Companies: Boost Run (BRUN), Ardent Health Partners, Inc. (ARDT) and Douglas AG (OtherDOUDF)
  TipRanks · 2026/9/18
• 评级变动
  D.A. Davidson Initiates Boost Run(BRUN.US) With Buy Rating, Announces Target Price $25
  \u5e02\u573a\u8d44\u8baf · 2026/5/13
• 评级变动
  D.A. Davidson Maintains Boost Run(BRUN.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/6/4
• 公司公告
  4: Cabaletta Bio | 4: Statement of changes in beneficial ownership of securities-Director Brun Scott C.
  SEC · 2026/6/11
• Craig-Hallum Maintains Boost Run(BRUN.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/10/2
• 公司公告
  4: Statement of changes in beneficial ownership of securities-Director Brun Scott C.
  SEC · 2025/7/4
• 公司公告
  4: Forte Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Brun Scott C.
  SEC · 2026/6/3
• 评级变动
  BTIG Initiates Boost Run(BRUN.US) With Buy Rating, Announces Target Price $45
  \u5e02\u573a\u8d44\u8baf · 2026/6/25
• 评级变动
  Craig-Hallum Maintains Boost Run(BRUN.US) With Buy Rating, Raises Target Price to $45
  \u5e02\u573a\u8d44\u8baf · 2026/6/4
• 评级变动
  BTIG Maintains Boost Run(BRUN.US) With Buy Rating, Maintains Target Price $45
  \u5e02\u573a\u8d44\u8baf · 2026/8/26
• D.A. Davidson Maintains Boost Run(BRUN.US) With Buy Rating, Maintains Target Price $45
  \u5e02\u573a\u8d44\u8baf · 2026/8/25
• 公司公告
  Forte Biosciences(Delisted) | 4: Statement of changes in beneficial ownership of securities-Director Brun Scott C.
  SEC · 2026/8/28
• 评级变动
  D.A. Davidson Maintains Boost Run(BRUN.US) With Buy Rating, Raises Target Price to $45
  \u5e02\u573a\u8d44\u8baf · 2026/6/1
• Boost Run(BRUN.US) Director Sells US$3.99 Million in Common Stock
  \u5e02\u573a\u8d44\u8baf · 2026/8/29

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。